Stem cell models, biosensor assay services, disease modeling

Tempo Bioscience specializes in advanced cell-based models and assay technologies aimed at enhancing drug development and disease modeling. Their offerings include patient-relevant human liver models for toxicity evaluation and blood-brain barrier models that are crucial for understanding drug interactions in the central nervous system. The company emphasizes the importance of innovative solutions in their research and development processes, particularly through the use of organoids—3D in vitro models that mimic the structure and function of actual tissues. This approach allows for more accurate representations of human diseases, facilitating better preclinical studies and drug discovery efforts.

In addition to their model systems, Tempo Bioscience provides a range of specialized culture media and assay solutions tailored for various cell types, including oligodendrocytes, astrocytes, and microglia. Their products are designed to support the growth and maintenance of these cells in laboratory settings, ensuring optimal conditions for research. The company also highlights the significance of trogocytosis, a process where immune cells exchange surface molecules, which can impact immune responses and disease progression. Overall, Tempo Bioscience is committed to advancing biomedical research through innovative technologies and high-quality cell culture solutions.

United States

Tempo Bioscience is a biotechnology company that develops human stem cells based disease models and biosensor enabling technologies for various applications.

Tempo Bioscience

Company Details